|
Sign In to gain access to subscriptions and/or personal tools.
|
A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury
S J Smith
Department of Neurosciences, University of Liverpool, Liverpool, UK
E Ellis
Clatterbridge Hospital, Wirral NHS Trust, Wirral, Liverpool, UK
S White
Department of Statistics and Mathematics, University of Liverpool, Liverpool, UK
A P Moore
Department of Neurosciences, University of Liverpool, Liverpool, UK
Objective: To assess dose–response relationships to a single dose of botulinum toxin ‘A’ in upper limb spasticity associated with stroke or head injury.
Design: A double-blind placebo-controlled randomized dose ranging study.
Setting: A regional centre for neuroscience and a neurorehabilitation outpatient clinic.
Subjects: Twenty-one hemiplegic patients with troublesome upper limb spasticity. Nineteen with stroke and two with head injury.
Main outcome measures: Spasticity (modified Ashworth), range of movement, posture (postural alignment and finger curl), disability (upper body dressing time and Frenchay Arm Test), patient-reported global assessment scale.
Results: Combining data from all doses of botulinum toxin there was a significant reduction in spasticity at the wrist and fingers associated with a greater range of passive movement at the wrist and less finger curl at rest. There was a tendency for a further reduction in spasticity at elbow and wrist to occur with increasing dose but not for finger spasticity or curl. Effects present at six weeks were lost by 12 weeks except for a small improvement in elbow range of movement at the 1500 Mu dose. There was no change in upper limb disability but a significant increase in patients' global assessment of benefit.
Conclusion: Botulinum toxin produced beneficial effects in spasticity and passive range of movement in the hemiplegic upper limb. Increasing the dose increased the magnitude of response for impairments in some muscle groups but had little effect on duration of response.
Clinical Rehabilitation, Vol. 14, No. 1,
5-13 (2000)
DOI: 10.1191/026921500666642221
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
D M Simpson, J M Gracies, S A Yablon, R Barbano, A Brashear, and the BoNT/TZD Study Team
Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study
J. Neurol. Neurosurg. Psychiatry,
April 1, 2009;
80(4):
380 - 385.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G.-C. Hu, Y.-C. Chuang, J.-P. Liu, K.-L. Chien, Y.-M. Chen, and Y.-F. Chen
Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes
Clinical Rehabilitation,
January 1, 2009;
23(1):
64 - 71.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, and Y. So
Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurology,
May 6, 2008;
70(19):
1691 - 1698.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-Y. Lim, J.-H. Koh, and N.-J. Paik
Intramuscular Botulinum Toxin-A Reduces Hemiplegic Shoulder Pain: A Randomized, Double-Blind, Comparative Study Versus Intraarticular Triamcinolone Acetonide
Stroke,
January 1, 2008;
39(1):
126 - 131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. P Yelnik, F. M Colle, I. V Bonan, and E. Vicaut
Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A
J. Neurol. Neurosurg. Psychiatry,
August 1, 2007;
78(8):
845 - 848.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ozcakir and K. Sivrioglu
Botulinum Toxin in Poststroke Spasticity
Clin. Med. Res.,
June 1, 2007;
5(2):
132 - 138.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Cheng, J. S. Chen, and R. P. Patel
Unlabeled uses of botulinum toxins: A review, part 2
Am. J. Health Syst. Pharm.,
February 1, 2006;
63(3):
225 - 232.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Manganotti and E. Amelio
Long-Term Effect of Shock Wave Therapy on Upper Limb Hypertonia in Patients Affected by Stroke
Stroke,
September 1, 2005;
36(9):
1967 - 1971.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. F. Gordon, A. Brashear, E. Elovic, D. Kassicieh, C. Marciniak, J. Liu, C. Turkel, and for the BOTOX Poststroke Spasticity Study Group
Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke
Neurology,
November 23, 2004;
63(10):
1971 - 1973.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H P Francis, D T Wade, L Turner-Stokes, R S Kingswell, C S Dott, and E A Coxon
Does reducing spasticity translate into functional benefit? An exploratory meta-analysis
J. Neurol. Neurosurg. Psychiatry,
November 1, 2004;
75(11):
1547 - 1551.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Delgado
Botulinum Neurotoxin Type A
J. Am. Acad. Ortho. Surg.,
September 1, 2003;
11(5):
291 - 294.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Brashear, M. F. Gordon, E. Elovic, V. D. Kassicieh, C. Marciniak, M. Do, C.-H. Lee, S. Jenkins, C. Turkel, and the Botox Post-Stroke Spasticity Study Group
Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke
N. Engl. J. Med.,
August 8, 2002;
347(6):
395 - 400.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D Pandyan, P. Vuadens, F. M. van Wijck, S. Stark, G. R Johnson, and M. P Barnes
Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox(R) to the elbow flexors in a unilateral stroke population
Clinical Rehabilitation,
June 1, 2002;
16(6):
654 - 660.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Gentleman
Rehabilitation after traumatic brain injury
Trauma,
October 1, 2001;
3(4):
193 - 204.
[Abstract]
[PDF]
|
|
|
|
|
